These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 17355733

  • 1. Effects of clarithromycin in patients with active rheumatoid arthritis.
    Ogrendik M.
    Curr Med Res Opin; 2007 Mar; 23(3):515-22. PubMed ID: 17355733
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: a 3-month, randomized, double-blind, placebo-controlled trial.
    Ogrendik M.
    Clin Ther; 2009 Aug; 31(8):1754-64. PubMed ID: 19808134
    [Abstract] [Full Text] [Related]

  • 3. Treatment of rheumatoid arthritis with roxithromycin: a randomized trial.
    Ogrendik M, Karagoz N.
    Postgrad Med; 2011 Sep; 123(5):220-7. PubMed ID: 21904105
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and tolerability of valdecoxib in treating the signs and symptoms of severe rheumatoid arthritis: a 12-week, multicenter, randomized, double-blind, placebo-controlled study.
    Gibofsky A, Rodrigues J, Fiechtner J, Berger M, Pan S.
    Clin Ther; 2007 Jun; 29(6):1071-85. PubMed ID: 17692722
    [Abstract] [Full Text] [Related]

  • 5. Polyarticular corticosteroid injection versus systemic administration in treatment of rheumatoid arthritis patients: a randomized controlled study.
    Furtado RN, Oliveira LM, Natour J.
    J Rheumatol; 2005 Sep; 32(9):1691-8. PubMed ID: 16142862
    [Abstract] [Full Text] [Related]

  • 6. Improved functional ability in patients with rheumatoid arthritis--longterm treatment with leflunomide versus sulfasalazine. European Leflunomide Study Group.
    Kalden JR, Scott DL, Smolen JS, Schattenkirchner M, Rozman B, Williams BD, Kvien TK, Jones P, Williams RB, Oed C, Rosenburg R, European Leflunomide Study Group.
    J Rheumatol; 2001 Sep; 28(9):1983-91. PubMed ID: 11550964
    [Abstract] [Full Text] [Related]

  • 7. A comparison of valdecoxib and naproxen in the treatment of rheumatoid arthritis symptoms.
    Williams GW, Kivitz AJ, Brown MT, Verburg KM.
    Clin Ther; 2006 Feb; 28(2):204-21. PubMed ID: 16678642
    [Abstract] [Full Text] [Related]

  • 8. A comparison of the efficacy and safety of celecoxib 200 mg and celecoxib 400 mg once daily in treating the signs and symptoms of psoriatic arthritis.
    Kivitz AJ, Espinoza LR, Sherrer YR, Liu-Dumaw M, West CR.
    Semin Arthritis Rheum; 2007 Dec; 37(3):164-73. PubMed ID: 17570469
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of tacrolimus in patients with rheumatoid arthritis: a double-blind trial.
    Yocum DE, Furst DE, Kaine JL, Baldassare AR, Stevenson JT, Borton MA, Mengle-Gaw LJ, Schwartz BD, Wisemandle W, Mekki QA, Tcrolimus Rheumatoid Arthritis Study Group.
    Arthritis Rheum; 2003 Dec; 48(12):3328-37. PubMed ID: 14673984
    [Abstract] [Full Text] [Related]

  • 10. Safety and efficacy of T-614 in the treatment of patients with active rheumatoid arthritis: a double blind, randomized, placebo-controlled and multicenter trial.
    Lü LJ, Teng JL, Bao CD, Han XH, Sun LY, Xu JH, Li XF, Wu HX.
    Chin Med J (Engl); 2008 Apr 05; 121(7):615-9. PubMed ID: 18466681
    [Abstract] [Full Text] [Related]

  • 11. Criteria for improvement in rheumatoid arthritis: alternatives to the American College of Rheumatology 20.
    Albert DA, Huang G, Dubrow G, Brensinger CM, Berlin JA, Williams HJ.
    J Rheumatol; 2004 May 05; 31(5):856-66. PubMed ID: 15124243
    [Abstract] [Full Text] [Related]

  • 12. Lack of efficacy of oral bovine type II collagen added to existing therapy in rheumatoid arthritis.
    McKown KM, Carbone LD, Kaplan SB, Aelion JA, Lohr KM, Cremer MA, Bustillo J, Gonzalez M, Kaeley G, Steere EL, Somes GW, Myers LK, Seyer JM, Kang AH, Postlethwaite AE.
    Arthritis Rheum; 1999 Jun 05; 42(6):1204-8. PubMed ID: 10366113
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of the efficacy and safety of pamapimod, a p38 MAP kinase inhibitor, in a double-blind, methotrexate-controlled study of patients with active rheumatoid arthritis.
    Cohen SB, Cheng TT, Chindalore V, Damjanov N, Burgos-Vargas R, Delora P, Zimany K, Travers H, Caulfield JP.
    Arthritis Rheum; 2009 Feb 05; 60(2):335-44. PubMed ID: 19180516
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of hydroxychloroquine sulphate in rheumatoid arthritis: a randomized, double-blind, placebo controlled clinical trial--an Indian experience.
    Das SK, Pareek A, Mathur DS, Wanchu A, Srivastava R, Agarwal GG, Chauhan RS.
    Curr Med Res Opin; 2007 Sep 05; 23(9):2227-34. PubMed ID: 17692155
    [Abstract] [Full Text] [Related]

  • 15. Improved health-related quality of life for patients with active rheumatoid arthritis receiving rituximab: Results of the Dose-Ranging Assessment: International Clinical Evaluation of Rituximab in Rheumatoid Arthritis (DANCER) Trial.
    Mease PJ, Revicki DA, Szechinski J, Greenwald M, Kivitz A, Barile-Fabris L, Kalsi J, Eames J, Leirisalo-Repo M.
    J Rheumatol; 2008 Jan 05; 35(1):20-30. PubMed ID: 18050385
    [Abstract] [Full Text] [Related]

  • 16. Should improvement in rheumatoid arthritis clinical trials be defined as fifty percent or seventy percent improvement in core set measures, rather than twenty percent?
    Felson DT, Anderson JJ, Lange ML, Wells G, LaValley MP.
    Arthritis Rheum; 1998 Sep 05; 41(9):1564-70. PubMed ID: 9751088
    [Abstract] [Full Text] [Related]

  • 17. Continuous indices of core data set measures in rheumatoid arthritis clinical trials: lower responses to placebo than seen with categorical responses with the American College of Rheumatology 20% criteria.
    Pincus T, Amara I, Koch GG.
    Arthritis Rheum; 2005 Apr 05; 52(4):1031-6. PubMed ID: 15818698
    [Abstract] [Full Text] [Related]

  • 18. Blocking the receptor for C5a in patients with rheumatoid arthritis does not reduce synovial inflammation.
    Vergunst CE, Gerlag DM, Dinant H, Schulz L, Vinkenoog M, Smeets TJ, Sanders ME, Reedquist KA, Tak PP.
    Rheumatology (Oxford); 2007 Dec 05; 46(12):1773-8. PubMed ID: 17965442
    [Abstract] [Full Text] [Related]

  • 19. CD4 coating, but not CD4 depletion, is a predictor of efficacy with primatized monoclonal anti-CD4 treatment of active rheumatoid arthritis.
    Mason U, Aldrich J, Breedveld F, Davis CB, Elliott M, Jackson M, Jorgensen C, Keystone E, Levy R, Tesser J, Totoritis M, Truneh A, Weisman M, Wiesenhutter C, Yocum D, Zhu J.
    J Rheumatol; 2002 Feb 05; 29(2):220-9. PubMed ID: 11838838
    [Abstract] [Full Text] [Related]

  • 20. A randomized, double-blind, multicenter, controlled clinical trial of cyclosporine plus chloroquine vs. cyclosporine plus placebo in early-onset rheumatoid arthritis.
    Miranda JM, Alvarez-Nemegyei J, Saavedra MA, Terán L, Galván-Villegas F, García-Figueroa J, Jara LJ, Barile L, GRECIA Group.
    Arch Med Res; 2004 Feb 05; 35(1):36-42. PubMed ID: 15036798
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.